TEST BANK FOR STAHL'S ESSENTIAL PSYCHOPHARMACOLOGY
NEUROSCIENTIFIC BASIS AND PRACTICAL APPLICATIONS 5TH
EDITION/ALL CHAPTERS 1-14
,TABLE OF CONTENTS
CHAPTER 1 CHEMICAL NEUROTRANSMISSION .................................................... 3
CHAPTER 2 TRANSPORTERS, RECEPTORS, AND ENZYMES AS TARGETS OF
PSYCHOPHARMACOLOGICAL DRUG ACTION ..................................................... 12
CHAPTER 3 ION CHANNELS AS TARGETS OF PSYCHOPHARMACOLOGICAL DRUG
ACTION ............................................................................................................. 21
CHAPTER 4 PSYCHOSIS AND SCHIZOPHRENIA .................................................... 29
CHAPTER 5 ANTIPSYCHOTIC AGENTS ................................................................. 45
CHAPTER 6 MOOD DISORDERS .......................................................................... 53
CHAPTER 7 ANTIDEPRESSANTS ......................................................................... 64
CHAPTER 8 MOOD STABILIZERS ........................................................................ 76
CHAPTER 9 ANXIETY DISORDERS AND ANXIOLYTICS .......................................... 94
CHAPTER 10 CHRONIC PAIN AND ITS TREATMENT .......................................... 101
CHAPTER 11 DISORDERS OF SLEEP AND WAKEFULNESS AND THEIR TREATMENT
....................................................................................................................... 111
CHAPTER 12 ATTENTION DEFICIT HYPERACTIVITY DISORDER AND ITS
TREATMENT .................................................................................................... 118
CHAPTER 13 DEMENTIA AND ITS TREATMENT................................................. 129
CHAPTER 14 IMPULSIVITY, COMPULSIVITY, AND ADDICTION .......................... 142
,TEST BANK FOR STAHL'S ESSENTIAL PSYCHOPHARMACOLOGY NEUROSCIENTIFIC BASIS AND PRACTICAL
APPLICATIONS 5TH EDITION/ALL CHAPTERS 1-14
CHAPTER 1 CHEMICAL NEUROTRANSMISSION
MULTIPLE CHOICE
1. A PATIENT WITH DEPRESSION MENTIONS TO THE NURSE, MY MOTHER SAYS DEPRESSION IS A
CHEMICAL DISORDER. WHAT DOES SHE MEAN? THE NURSES RESPONSE IS BASED ON THE THEORY THAT
DEPRESSION PRIMARILY INVOLVES WHICH OF THE FOLLOWING NEUROTRANSMITTERS?
A. CORTISOL AND GABA
B. COMT AND GLUTAMATE
C. MONAMINE AND GLYCINE
D. SEROTONIN AND NOREPINEPHRINE
CORRECT ANSWER>>D
ONE POSSIBLE CAUSE OF DEPRESSION IS THOUGHT TO INVOLVE ONE OR MORE NEUROTRANSMITTERS.
SEROTONIN AND NOREPINEPHRINE HAVE BEEN FOUND TO BE IMPORTANT IN THE REGULATION OF
DEPRESSION. THERE IS NO RESEARCH TO SUPPORT THAT THE OTHER OPTIONS PLAY A SIGNIFICANT
ROLE IN THE DEVELOPMENT OF DEPRESSION.
2. A PATIENT HAS EXPERIENCED A STROKE (CEREBRAL VASCULAR ACCIDENT) THAT HAS RESULTED
IN DAMAGE TO THE BROCA AREA. WHICH EVALUATION DOES THE NURSE CONDUCT TO REINFORCE THIS
DIAGNOSIS?
A. OBSERVING THE PATIENT PICK UP A SPOON
B. ASKING THE PATIENT TO RECITE THE ALPHABET
C. MONITORING THE PATIENTS BLOOD PRESSURE
D. COMPARING THE PATIENTS GRIP STRENGTH IN BOTH HANDS
CORRECT ANSWER>>B
ACCIDENTS OR STROKES THAT DAMAGE BROCAS AREA MAY RESULT IN THE INABILITY TO SPEAK (I.E.,
MOTOR APHASIA). FINE MOTOR SKILLS, BLOOD PRESSURE CONTROL, AND MUSCLE STRENGTH ARE NOT
CONTROLLED BY THE BROCA AREA OF THE LEFT FRONTAL LOBE.
3. THE PATIENT DIAGNOSED WITH SCHIZOPHRENIA ASKS WHY PSYCHOTROPIC MEDICATIONS ARE
ALWAYS PRESCRIBED BY THE DOCTOR. THE NURSES ANSWER WILL BE BASED ON INFORMATION THAT
THE THERAPEUTIC ACTION OF PSYCHOTROPIC DRUGS IS THE RESULT OF THEIR EFFECT ON:
A. THE TEMPORAL LOBE; ESPECIALLY WERNICKES AREA
B. DENDRITES AND THEIR ABILITY TO TRANSMIT ELECTRICAL IMPULSES
C. THE REGULATION OF NEUROTRANSMITTERS ESPECIALLY DOPAMINE
, D. THE PERIPHERAL NERVOUS SYSTEM SENSITIVITY TO THE PSYCHOTROPIC MEDICATIONS
CORRECT ANSWER>>C
MEDICATIONS USED TO TREAT PSYCHIATRIC DISORDERS OPERATE IN AND AROUND THE SYNAPTIC CLEFT
AND HAVE ACTION AT THE NEUROTRANSMITTER LEVEL, ESPECIALLY IN THE CASE OF SCHIZOPHRENIA,
ON DOPAMINE. THE WERNICKES AREA, DENDRITE FUNCTION, OR THE SENSITIVITY OF THE PERIPHERAL
NERVOUS SYSTEM ARE NOT RELEVANT TO EITHER SCHIZOPHRENIA OR PSYCHOTROPIC MEDICATIONS.
4. A STUDENT NURSE MUTTERS THAT IT SEEMS ENTIRELY UNNECESSARY TO HAVE TO STRUGGLE
WITH UNDERSTANDING THE ANATOMY AND PHYSIOLOGY OF THE NEUROLOGIC SYSTEM. THE MENTOR
WOULD BASE A RESPONSE ON THE UNDERSTANDING THAT IT IS:
A. NECESSARY BUT GENERALLY FOR PSYCHIATRIC NURSES WHO FOCUS PRIMARILY ON
BEHAVIORAL INTERVENTIONS
B. A COMPLEX UNDERTAKING THAT ADVANCE PRACTICE PSYCHIATRIC NURSES FREQUENTLY USE
IN THEIR PRACTICE
C. IMPORTANT PRIMARILY FOR THE NURSING ASSESSMENT OF PATIENTS WITH BRAIN TRAUMA
CAUSED COGNITIVE SYMPTOMS
D. NECESSARY FOR PLANNING PSYCHIATRIC CARE FOR ALL PATIENTS ESPECIALLY THOSE
EXPERIENCING PSYCHIATRIC DISORDERS
CORRECT ANSWER>>D
NURSES MUST UNDERSTAND THAT MANY SYMPTOMS OF PSYCHIATRIC DISORDERS HAVE A
NEUROLOGIC BASIS, ALTHOUGH THE SYMPTOMS ARE MANIFESTED BEHAVIORALLY. THIS
UNDERSTANDING FACILITATES EFFECTIVE CARE PLANNING. THE FOUNDATION OF KNOWLEDGE IS NOT
USED EXCLUSIVELY BY ADVANCED PRACTICE PSYCHIATRIC NURSES NOR IS IT RELEVANT FOR ONLY
NEUROSCIENTIFIC BASIS AND PRACTICAL APPLICATIONS 5TH
EDITION/ALL CHAPTERS 1-14
,TABLE OF CONTENTS
CHAPTER 1 CHEMICAL NEUROTRANSMISSION .................................................... 3
CHAPTER 2 TRANSPORTERS, RECEPTORS, AND ENZYMES AS TARGETS OF
PSYCHOPHARMACOLOGICAL DRUG ACTION ..................................................... 12
CHAPTER 3 ION CHANNELS AS TARGETS OF PSYCHOPHARMACOLOGICAL DRUG
ACTION ............................................................................................................. 21
CHAPTER 4 PSYCHOSIS AND SCHIZOPHRENIA .................................................... 29
CHAPTER 5 ANTIPSYCHOTIC AGENTS ................................................................. 45
CHAPTER 6 MOOD DISORDERS .......................................................................... 53
CHAPTER 7 ANTIDEPRESSANTS ......................................................................... 64
CHAPTER 8 MOOD STABILIZERS ........................................................................ 76
CHAPTER 9 ANXIETY DISORDERS AND ANXIOLYTICS .......................................... 94
CHAPTER 10 CHRONIC PAIN AND ITS TREATMENT .......................................... 101
CHAPTER 11 DISORDERS OF SLEEP AND WAKEFULNESS AND THEIR TREATMENT
....................................................................................................................... 111
CHAPTER 12 ATTENTION DEFICIT HYPERACTIVITY DISORDER AND ITS
TREATMENT .................................................................................................... 118
CHAPTER 13 DEMENTIA AND ITS TREATMENT................................................. 129
CHAPTER 14 IMPULSIVITY, COMPULSIVITY, AND ADDICTION .......................... 142
,TEST BANK FOR STAHL'S ESSENTIAL PSYCHOPHARMACOLOGY NEUROSCIENTIFIC BASIS AND PRACTICAL
APPLICATIONS 5TH EDITION/ALL CHAPTERS 1-14
CHAPTER 1 CHEMICAL NEUROTRANSMISSION
MULTIPLE CHOICE
1. A PATIENT WITH DEPRESSION MENTIONS TO THE NURSE, MY MOTHER SAYS DEPRESSION IS A
CHEMICAL DISORDER. WHAT DOES SHE MEAN? THE NURSES RESPONSE IS BASED ON THE THEORY THAT
DEPRESSION PRIMARILY INVOLVES WHICH OF THE FOLLOWING NEUROTRANSMITTERS?
A. CORTISOL AND GABA
B. COMT AND GLUTAMATE
C. MONAMINE AND GLYCINE
D. SEROTONIN AND NOREPINEPHRINE
CORRECT ANSWER>>D
ONE POSSIBLE CAUSE OF DEPRESSION IS THOUGHT TO INVOLVE ONE OR MORE NEUROTRANSMITTERS.
SEROTONIN AND NOREPINEPHRINE HAVE BEEN FOUND TO BE IMPORTANT IN THE REGULATION OF
DEPRESSION. THERE IS NO RESEARCH TO SUPPORT THAT THE OTHER OPTIONS PLAY A SIGNIFICANT
ROLE IN THE DEVELOPMENT OF DEPRESSION.
2. A PATIENT HAS EXPERIENCED A STROKE (CEREBRAL VASCULAR ACCIDENT) THAT HAS RESULTED
IN DAMAGE TO THE BROCA AREA. WHICH EVALUATION DOES THE NURSE CONDUCT TO REINFORCE THIS
DIAGNOSIS?
A. OBSERVING THE PATIENT PICK UP A SPOON
B. ASKING THE PATIENT TO RECITE THE ALPHABET
C. MONITORING THE PATIENTS BLOOD PRESSURE
D. COMPARING THE PATIENTS GRIP STRENGTH IN BOTH HANDS
CORRECT ANSWER>>B
ACCIDENTS OR STROKES THAT DAMAGE BROCAS AREA MAY RESULT IN THE INABILITY TO SPEAK (I.E.,
MOTOR APHASIA). FINE MOTOR SKILLS, BLOOD PRESSURE CONTROL, AND MUSCLE STRENGTH ARE NOT
CONTROLLED BY THE BROCA AREA OF THE LEFT FRONTAL LOBE.
3. THE PATIENT DIAGNOSED WITH SCHIZOPHRENIA ASKS WHY PSYCHOTROPIC MEDICATIONS ARE
ALWAYS PRESCRIBED BY THE DOCTOR. THE NURSES ANSWER WILL BE BASED ON INFORMATION THAT
THE THERAPEUTIC ACTION OF PSYCHOTROPIC DRUGS IS THE RESULT OF THEIR EFFECT ON:
A. THE TEMPORAL LOBE; ESPECIALLY WERNICKES AREA
B. DENDRITES AND THEIR ABILITY TO TRANSMIT ELECTRICAL IMPULSES
C. THE REGULATION OF NEUROTRANSMITTERS ESPECIALLY DOPAMINE
, D. THE PERIPHERAL NERVOUS SYSTEM SENSITIVITY TO THE PSYCHOTROPIC MEDICATIONS
CORRECT ANSWER>>C
MEDICATIONS USED TO TREAT PSYCHIATRIC DISORDERS OPERATE IN AND AROUND THE SYNAPTIC CLEFT
AND HAVE ACTION AT THE NEUROTRANSMITTER LEVEL, ESPECIALLY IN THE CASE OF SCHIZOPHRENIA,
ON DOPAMINE. THE WERNICKES AREA, DENDRITE FUNCTION, OR THE SENSITIVITY OF THE PERIPHERAL
NERVOUS SYSTEM ARE NOT RELEVANT TO EITHER SCHIZOPHRENIA OR PSYCHOTROPIC MEDICATIONS.
4. A STUDENT NURSE MUTTERS THAT IT SEEMS ENTIRELY UNNECESSARY TO HAVE TO STRUGGLE
WITH UNDERSTANDING THE ANATOMY AND PHYSIOLOGY OF THE NEUROLOGIC SYSTEM. THE MENTOR
WOULD BASE A RESPONSE ON THE UNDERSTANDING THAT IT IS:
A. NECESSARY BUT GENERALLY FOR PSYCHIATRIC NURSES WHO FOCUS PRIMARILY ON
BEHAVIORAL INTERVENTIONS
B. A COMPLEX UNDERTAKING THAT ADVANCE PRACTICE PSYCHIATRIC NURSES FREQUENTLY USE
IN THEIR PRACTICE
C. IMPORTANT PRIMARILY FOR THE NURSING ASSESSMENT OF PATIENTS WITH BRAIN TRAUMA
CAUSED COGNITIVE SYMPTOMS
D. NECESSARY FOR PLANNING PSYCHIATRIC CARE FOR ALL PATIENTS ESPECIALLY THOSE
EXPERIENCING PSYCHIATRIC DISORDERS
CORRECT ANSWER>>D
NURSES MUST UNDERSTAND THAT MANY SYMPTOMS OF PSYCHIATRIC DISORDERS HAVE A
NEUROLOGIC BASIS, ALTHOUGH THE SYMPTOMS ARE MANIFESTED BEHAVIORALLY. THIS
UNDERSTANDING FACILITATES EFFECTIVE CARE PLANNING. THE FOUNDATION OF KNOWLEDGE IS NOT
USED EXCLUSIVELY BY ADVANCED PRACTICE PSYCHIATRIC NURSES NOR IS IT RELEVANT FOR ONLY
